Authors/Disclosures
|
David Z. Wang, DO, FAHA, FAAN
(BNI, Neurology, Stroke)
|
Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome. |
|
Christina Azevedo, MD, FAAN
(University of Southern California)
|
Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Smith, Henning & Berman LLP. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. |
|
Deepak S. Nair, MD
(OSF HealthCare)
|
Dr. Nair has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Rachel W. Pan, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Arun V. Talkad, MD, BA
(OSF Healthcare)
|
Dr. Talkad has nothing to disclose. |